Literature DB >> 2933098

Identification and quantitation of protein S in human platelets.

H P Schwarz, M J Heeb, J D Wencel-Drake, J H Griffin.   

Abstract

Gel filtered human platelets contaminated with less than 0.02% of plasma protein S contained 490 ng of protein S antigen per 3 X 10(8) platelets, equivalent to 2.5% of protein S in whole blood. Three patients with heterozygous plasma protein S deficiency, a congenital disorder associated with venous thrombotic disease, had platelet protein S antigen levels that were 40% of the mean platelet level in ten normal volunteers. In immunoblotting analysis, platelet protein S was indistinguishable from plasma protein S. Thrombin stimulation of platelets caused release of 63% of total protein S antigen and this release was abolished when platelets were preincubated with metabolic inhibitors. Thrombin effected limited proteolysis of platelet protein S and this reaction was inhibited by calcium ions. Immunofluorescent staining of platelets using protein S antibodies demonstrated that protein S colocalized with fibrinogen, an established alpha-granule protein. Thus, human platelets contain protein S in alpha granules that can be released by thrombin stimulation. The released protein S may bind to stimulated platelets and thereby promote and localize the anticoagulant activity of activated protein C on the platelet surface.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2933098

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  27 in total

Review 1.  The interaction between complement component C4b-binding protein and the vitamin K-dependent protein S forms a link between blood coagulation and the complement system.

Authors:  M Hessing
Journal:  Biochem J       Date:  1991-08-01       Impact factor: 3.857

2.  Respiratory burst oxidase and three of four oxidase-related polypeptides are associated with the cytoskeleton of human neutrophils.

Authors:  R C Woodman; J M Ruedi; A J Jesaitis; N Okamura; M T Quinn; R M Smith; J T Curnutte; B M Babior
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

3.  Platelet protein S directly inhibits procoagulant activity on platelets and microparticles.

Authors:  Fabian Stavenuiter; Nicole F Davis; Erning Duan; Andrew J Gale; Mary J Heeb
Journal:  Thromb Haemost       Date:  2012-12-13       Impact factor: 5.249

4.  Phosphorylation of protein S by platelet kinases enhances its activated protein C cofactor activity.

Authors:  Fabian Stavenuiter; Andrew J Gale; Mary J Heeb
Journal:  FASEB J       Date:  2013-04-11       Impact factor: 5.191

5.  Direct measurement of vitamin K-dependent enzymes in various isolated and cultured tumor and non-tumor cells.

Authors:  M A de Boer-van den Berg; M P Uitendaal; C Vermeer
Journal:  Mol Cell Biochem       Date:  1987-05       Impact factor: 3.396

6.  Platelet protein S limits venous but not arterial thrombosis propensity by controlling coagulation in the thrombus.

Authors:  Sara Calzavarini; Raja Prince-Eladnani; François Saller; Luca Bologna; Laurent Burnier; Anne C Brisset; Claudia Quarroz; Maria Desiré Reina Caro; Vladimir Ermolayev; Yasuhiro Matsumura; José A Fernández; Tilman M Hackeng; John H Griffin; Anne Angelillo-Scherrer
Journal:  Blood       Date:  2020-05-28       Impact factor: 22.113

7.  Regulation of venous thrombosis by platelet protein S.

Authors:  Rinku Majumder
Journal:  Blood       Date:  2020-05-28       Impact factor: 22.113

8.  Vitamin K-dependent protein S in Leydig cells of human testis.

Authors:  J Malm; X H He; A Bjartell; L Shen; P A Abrahamsson; B Dahlbäck
Journal:  Biochem J       Date:  1994-09-15       Impact factor: 3.857

9.  LPS-Toll-Like Receptor-Mediated Signaling on Expression of Protein S and C4b-Binding Protein in the Liver.

Authors:  Tatsuya Hayashi; Koji Suzuki
Journal:  Gastroenterol Res Pract       Date:  2010-08-18       Impact factor: 2.260

Review 10.  Platelet alpha-granules: basic biology and clinical correlates.

Authors:  Price Blair; Robert Flaumenhaft
Journal:  Blood Rev       Date:  2009-05-17       Impact factor: 8.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.